PPD

AUGUST 5, 2024

Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease that is caused or influenced by multiple factors. The clinical sites working on these trials are highly experienced and have a deep understanding of the complexities of successfully running PAH clinical trials. None offers a cure for PAH.

Clinical Trials 98

Clinical Trials Trials Clinical Research Disease 98

Drug Target Review

OCTOBER 25, 2024

How does precision neuroscience differ from traditional approaches in the treatment of neurodegenerative diseases, and what advantages does it offer? Traditionally, Alzheimer’s disease is diagnosed by clinical examination, medical history and cognitive testing.

Disease 59

Disease Clinical Trials Therapies Science 59

Conversations in Drug Development Trends

NOVEMBER 3, 2022

BioPharma Dive interviewed our Derek Ansel on how to conduct psychedelic clinical research. In April 2022, the Food and Drug Administration (FDA) issued draft guidance on developing a “Race and Ethnicity Diversity Plan” for clinical trials. But in rare disease trials, that can be challenging given the barriers inherent in U.S.

Disease 52

Disease Clinical Trials Trials International 52

Olympian Clinical Research

SEPTEMBER 3, 2020

The tough thing about depression is that the disease is wildly indiscriminate, affecting patients of every age, gender, and ethnicity. For patients that struggle with depression, the disease can have devastating impacts both mentally, physically, and emotionally.

Clinical Trials 98

Clinical Trials Treatment Clinical Research Trials 98

Drug Target Review

SEPTEMBER 5, 2024

I am a pharmacist by training and continued with a PhD in Clinical Pharmacology. However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

PPD

MARCH 13, 2024

In every early phase clinical trial, the transportation, chain of custody, environmental monitoring and subsequent analysis of biological samples are the cornerstones of a successful, robust and quality outcome. Within cell therapy clinical trials, apheresis collections contribute to the specific constituents of the given therapy.

Clinical Development 98

Clinical Development Clinical Trials Therapies Trials 98

The Pharma Data

MAY 6, 2021

INDIANAPOLIS , May 6, 2021 /PRNewswire/ — With a goal of integrating data and technology to help streamline diabetes management, Eli Lilly and Company (NYSE: LLY) signed strategic international agreements with four companies – DexCom, Inc., Glooko Inc. ” About Diabetes An estimated 463 million adults worldwide 1 have diabetes. .”

International 52

International Therapies Disease Production 52

The Pharma Data

NOVEMBER 10, 2020

Biomarkers will be critical to developing precision medicine for Alzheimer’s disease. Although a few are out there, phosphorylated tau (P-tau) may enable even earlier and more accurate detection, according to Eli Lilly-associated researchers speaking at the Clinical Trials on Alzheimer’s Disease (CTAD) virtual conference in early November.

Disease 52

Disease Clinical Trials Trials Research 52

PPD

OCTOBER 9, 2023

Education on the disease state and regular reinforcement. Travel services: A patient in a rare disease trial contacted her concierge expressing concern about her ability to travel to her appointments, as she and her husband shared a vehicle. Training through a device and/or app to support protocol requirements.

Clinical Trials 98

Clinical Trials Trials Compliance International 98

Vial

JUNE 12, 2024

Utilizing PROs enables the active participation of patients in their care outcomes – both in a clinical setting and in clinical research. PROs in clinical trials are important as they capture the patient’s perspective and ensure that the impact of an intervention is comprehensively evaluated. For HF, Savarese et al.

Clinical Trials 52

Clinical Trials Trials FDA Clinical Research 52

The Pharma Data

JUNE 26, 2021

Together with our research partners, BIG conducts landmark, practice-changing trials that can have a significant impact on the lives of women with breast cancer,” sa id David Cameron , Chair of the BIG Executive Board. Adjuvant therapy helps prevent and delay the progression of disease into the later setting.

Clinical Trials 52

Clinical Trials International Trials Therapies 52

The Pharma Data

JANUARY 25, 2021

“The establishment of an Advisory Board focusing on Alzheimer’s disease, and the recruitment of such an impressive group of scientific and clinical leaders in this field is an extremely important step forward for the Company,” stated Paul Brennan, NervGen’s President & CEO. Dr.

Disease 40

Disease Clinical Development Molecular Biology Treatment 40

The Pharma Data

NOVEMBER 10, 2020

P otential to be a safer and effective alternative to the intravenous immunotherapies currently used for Crohn’s Disease. Crohn’s Disease Therapeutics Market Size $4.7 Phase1b/2 clinical study to be conducted in the United States and several European countries. Billion by 2025. and Europe.

Clinical Trials 40

Clinical Trials Science Disease Trials 40

The Pharma Data

NOVEMBER 1, 2020

Dr Nurbhai has more than 25 years of experience and a strong track record in the strategic and operational leadership of all phases of clinical research and development at companies across Europe and the US. The Company is managed by a team with broad international, commercial and clinical-science experience.

Clinical Pharmacology 52

Clinical Pharmacology Small Molecule Clinical Research Science 52

Drug Target Review

SEPTEMBER 26, 2023

Human derived induced pluripotent stem cells (hiPSCs) have revolutionised research and are increasingly used for toxicology screening and disease modelling. 27,28 Since the advent of hiPSC technology almost two decades ago enormous progress has been made in many areas of research. International Union of Pharmacology.

Drugs 111

Drugs FDA Disease Animal Testing 111

Vial

MARCH 25, 2024

Worldwide Clinical Trials is a mid-size, full-service global contract research organization (CRO) that works with biotech and pharma to advance new medications. With an international presence in nearly 60 countries, Worldwide is supported by over 3,400 team members.

Clinical Trials 52

Clinical Trials Trials Clinical Development Clinical Research 52

PPD

OCTOBER 31, 2024

In response, the PPD clinical research business of Thermo Fisher Scientific conducted its third global survey of 150 drug developers to capture a comprehensive view of these evolving trends. This issue is particularly pronounced for rare diseases and trials requiring diverse patient populations.

Drug Development 52

Drug Development Clinical Trials Trials Drugs 52

Vial

MAY 15, 2024

Vial | Pros and Cons The unprecedented consequences of the COVID-19 pandemic gave rise to the advent of decentralized clinical trials (DCTs), which are studies that use telemedicine and remote or local healthcare professionals to enable participants to join from different locations. billion and now functions as a subsidiary.

Clinical Trials 52

Clinical Trials Trials Clinical Research Compliance 52

PPD

DECEMBER 16, 2024

The drug development industry faces rising costs and increasingly complex protocols as top challenges, with 49% of developers citing costs as their primary concern and 39% pointing to protocol complexity as a key hurdle, according to a recent survey of 150 drug developers worldwide by the PPD clinical research business of Thermo Fisher Scientific.

Drug Development 52

Drug Development Compliance Clinical Trials Trials 52

The Pharma Data

AUGUST 9, 2021

POLARIX is being conducted in collaboration with The Lymphoma Study Association (LYSA) and The Lymphoma Academic Research Organisation (LYSARC). The Lymphoma Academic Research Organisation, or LYSARC, is the LYSA operational structure that conducts clinical research projects on lymphomas at the international level.

International 52

International Treatment Pharmacokinetics Therapies 52

Vial

APRIL 10, 2024

The strong commitment to innovation allows IQVIA to provide advanced analytics, technology solutions, and industry-specific expertise in the health information technologies and clinical research domains. IQVIA has a vast collection of healthcare information, including over 1.2 increase on a reported basis and an 4.8%

Clinical Trials 52

Clinical Trials Trials Clinical Research Compliance 52

Vial

JUNE 18, 2024

Recognizing the issue of underrepresentation of racial and ethnic minorities in clinical trials, e.g., for Alzheimer’s Disease (AD), researchers have sought to understand the barriers and facilitators for patient access better. Although AD disproportionately affects U.S. Specifically, U.S. Specifically, U.S. Rubin et al.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

The Pharma Data

JANUARY 6, 2021

“Further, PDE4-inhibition is a well-documented pharmacological target for a number of other inflammatory indications, and we look forward to advancing our clinical research to realize the full potential of orismilast for the benefit of the millions of patients living with inflammatory conditions globally,” adds Professor Sommer.

FDA Approval 52

FDA Approval FDA Clinical Development Clinical Research 52

PerkinElmer

JANUARY 21, 2022

Dementias include a wide spectrum of neurodegenerative disorders, including Parkinson’s disease, Motor Neuron diseases, Multiple Sclerosis, Huntington’s disease, Creutzfeldt–Jakob disease, and Alzheimer’s disease. That’s right, the MRC says. To achieve that, Prof. I believe that is a goal worth pursuing.”

Cell Biology 52

Cell Biology Disease Treatment Science 52

Conversations in Drug Development Trends

APRIL 3, 2024

Leveraging Real-World Data : Utilizing electronic health records and disease registries can help identify potential candidates more efficiently. Partnering with advocacy organizations can help them to explain radiopharmaceuticals to their members and encourage participation.

Trials 81

Trials Clinical Trials Compliance Treatment 81

Vial

MAY 8, 2024

A Brief Introduction Medrio was founded in 2005 with the mission to revolutionize clinical research with the creation of the first cloud-based EDC system, designed to simplify data collection without requiring advanced programming skills. Established in 2020, Vial has rapidly emerged as a leading technology-driven CRO.

Clinical Trials 52

Clinical Trials Trials Clinical Research Laboratories 52

The Pharma Data

NOVEMBER 10, 2020

According to data published on the WHO website, more than 46 million people have been tested positive for COVID-19, with over 1 million patients in more than 200 counties died from the disease as of November 2 nd , 2020. SHANGHAI , Nov.

Hospitals 52

Hospitals Clinical Trials Treatment Therapies 52

The Pharma Data

JANUARY 14, 2021

Dickstein enjoyed 30 years in the pharmaceutical field before retiring in 1998 as the vice president of clinical research for Transcend Therapeutics, Inc. As a seasoned scientist, Dr. Dickstein spent significant time conducting research. Early in his career, Dr. Dickstein held appointments with the U.S.

Laboratories 52

Laboratories Clinical Research Hospitals Pharmaceuticals 52

The Pharma Data

OCTOBER 26, 2020

University International Institute for Global Health (UNU-IIGH). The topics covered in the BMJ series, include a broad range of social and medical factors influencing women’s health, such as sexual and reproductive health; violence against women, mental health, noncommunicable diseases, climate change, limited.

Disease 52

Disease Clinical Research Government International 52

The Anticancer Fund

OCTOBER 18, 2023

Best response was partial response in one patient, and stable disease in 11 (36%) patients. The authors report that of the 5 cases, four showed clinical benefit, including one complete response, one partial response and two stable disease. Adverse events were manageable and reversible.

Drugs 64

Drugs Trials Clinical Trials Treatment 64

The Pharma Data

DECEMBER 27, 2020

Orelabrutinib is a BTK inhibitor developed by InnoCare for the treatment of cancer and autoimmune diseases. Professor and Director of the Department of Internal Medicine and Lymphoma, Peking University Cancer Hospital. “We China represents a large pharmaceutical market. 1 Source: [link].

Science 52

Science Hospitals Treatment Clinical Trials 52

The Pharma Data

MARCH 15, 2021

Clinical research is a key component of developing. A critical component of our medicinal product development is clinical research. This involves conducting clinical trials in humans to evaluate the safety and efficacy of new pharmaceutical products. new medicines.

Clinical Trials 40

Clinical Trials Trials Clinical Development Clinical Research 40

The Pharma Data

JANUARY 17, 2021

It was co-sponsored by Merck and Bayer, conducted with the scientific oversight of the Canadian VIGOUR Centre and the Duke Clinical Research Institute. Myelosuppression happens when radiation damages internal organs, including bone marrow. Aurinia Pharmaceutical’s Voclosporin for Lupus Nephritis.

FDA 52

FDA Small Molecule Immune Response Hospitals 52

The Pharma Data

JANUARY 31, 2021

The life sciences ecosystem will need to capitalize on this momentum going forward to solve other diseases that will define the 21 st century. . According to Nature Biotechnology, “81% of researchers are constrained by the inadequate quantity and quality of biospecimens and 80% of companies find accessing materials difficult.”.

Research 52

Research Clinical Trials Trials Science 52

The Pharma Data

JANUARY 13, 2021

Clinical data from studies of ensifentrine in the treatment of other respiratory diseases have shown ensifentrine improved lung function, reduced inflammation in the lungs* and reduced symptoms of cough and sputum production. Ensifentrine has been well tolerated in clinical trials involving more than 1,300 people. .

Hospitals 52

Hospitals Clinical Trials Therapies Treatment 52

The Pharma Data

JANUARY 24, 2021

It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. It will be run through the NIAID-supported Infectious Diseases Clinical Research Consortium (IDCRC), with support from the Bill & Melinda Gates Foundation.

Long-Term Care Facilities 52

Long-Term Care Facilities Trials Virus Clinical Trials 52

The Pharma Data

FEBRUARY 18, 2022

The global mRNA technology transfer hub was established in 2021 to support manufacturers in low- and middle-income countries to produce their own vaccines, ensuring that they have all the necessary operating procedures and know-how to manufacture mRNA vaccines at scale and according to international standards.

Vaccine 52

Vaccine Production Clinical Research Laboratories 52